Plus Therapeutics
Price & Volume
Stats
See moreOpen | $0.68 |
Previous Close | $0.72 |
Day Range | $0.66-$0.69 |
52W Range | $0.16-$2.31 |
Market Cap | $71.7M |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $5.3M |
Revenue Growth (YoY) | 8.7% |
Gross Profit (12 Mos) | -$2.7M |
Diluted EPS | -$1.35 |
News
See moreYahoo Finance • 15 days ago
Plus Therapeutics (PSTV) Soars 40% as Firm Seals Partnership with United Healthcare
Yahoo Finance • 16 days ago
Plus Therapeutics Announces National Coverage Agreement with UnitedHealthcare For CNS Cancer Diagnostic Kit
Yahoo Finance • 16 days ago
Plus Therapeutics Announces National Coverage Agreement with UnitedHealthcare Insurance Company for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
Yahoo Finance • 19 days ago
Plus Therapeutics receives $1.9M CPRIT payment for cancer program
About
CEO | Dr. Marc H. Hedrick M.B.A., M.D. |
CFO | Mr. Andrew J. Sims CPA |
Address | 2710 Reed Road, Houston, TX, United States, 77051 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 21 |
